Review recent data supporting safety and efficacy of B-cell-depleting agents for RA, as illustrated by data presented at American College of Rheumatology 2007 Annual Meeting. Medscape Rheumatology
Expert commentary by Stanley Cohen, MD, on the evidence for benefits and adverse effects of biologic therapies and their most appropriate utilization in different patient groups. Medscape Rheumatology
A patient with rheumatoid arthritis on methotrexate (MTX) is scheduled for surgery; should MTX be discontinued, and if so, for how long? Medscape Rheumatology
Hand bone densitometry (DEXA) is better than radiography for assessing bone involvement in patients with early rheumatoid arthritis, according to a report in the November issue of the Annals of the Rheumatic Diseases. Reuters Health Information
How does the burden of pain in FM patients compare with that in patients with other chronic pain conditions? International Journal of Clinical Practice
Markers for disease activity and outcomes in rheumatoid arthritis are crucial for tailoring the treatment to the needs of each individual Future Rheumatology
